> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Glenmark Pharma Recalls Potassium Chloride
- URL: https://www.fdaweb.com/glenmark-pharma-recalls-potassium-chloride/
- Published: 2024-06-25T12:00:00.000Z
- Updated: 2026-09-14T14:34:08.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157249

Glenmark Pharmaceuticals is recalling (Class 1) 114 batches of potassium chloride extended-release capsules, USP (750 mg) 10 mEq K, due to dissolution failures. “The failed dissolution of potassium chloride extended release capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heartbeat that can lead to cardiac arrest, a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/glenmark-pharmaceuticals-inc-usa-issues-voluntary-nationwide-recall-potassium-chloride-extended?utm%5Fmedium=email&utm%5Fsource=govdelivery) says. Potassium chloride extended-release capsules are used for treating patients with low potassium.